Your browser doesn't support javascript.
loading
A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
Wang, Yingcong; Huang, Jing; Li, Bo; Xue, Han; Tricot, Guido; Hu, Liangning; Xu, Zhijian; Sun, Xiaoxiang; Chang, Shuaikang; Gao, Lu; Tao, Yi; Xu, Hongwei; Xie, Yongsheng; Xiao, Wenqin; Yu, Dandan; Kong, Yuanyuan; Chen, Gege; Sun, Xi; Lian, Fulin; Zhang, Naixia; Wu, Xiaosong; Mao, Zhiyong; Zhan, Fenghuang; Zhu, Weiliang; Shi, Jumei.
Afiliação
  • Wang Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Huang J; Shanghai Institute of Precision Medicine, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li B; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and University of Chinese Academy of Sciences, Shanghai, China.
  • Xue H; Shanghai Institute of Precision Medicine, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Tricot G; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
  • Hu L; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xu Z; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and University of Chinese Academy of Sciences, Shanghai, China.
  • Sun X; Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Chang S; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Gao L; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Tao Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xu H; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
  • Xie Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xiao W; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Yu D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Kong Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Chen G; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Sun X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Lian F; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and University of Chinese Academy of Sciences, Shanghai, China.
  • Zhang N; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and University of Chinese Academy of Sciences, Shanghai, China.
  • Wu X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Mao Z; Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Zhan F; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
  • Zhu W; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and University of Chinese Academy of Sciences, Shanghai, China. shijumei@tongji.edu.cn wlzhu@simm.ac.cn.
  • Shi J; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. shijumei@tongji.edu.cn wlzhu@simm.ac.cn.
Cancer Res ; 80(3): 536-548, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31732653
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Inibidores Enzimáticos / Bibliotecas de Moléculas Pequenas / ATPases Associadas a Diversas Atividades Celulares / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Inibidores Enzimáticos / Bibliotecas de Moléculas Pequenas / ATPases Associadas a Diversas Atividades Celulares / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article